Researchers developed a deep learning-driven MASLD classification system for precision risk management.
Key Details
- 1Study analyzed 1,111 liver biopsies to train a deep LASSO model using six clinical indicators.
- 2Algorithm defined four MASLD subtypes with distinct risk profiles for hepatic and extrahepatic complications.
- 3External validation performed in cohorts of 6,172 and 7,406 adults; clustering was consistent.
- 4Cluster 4 displayed highest risk for combined cardiovascular, liver, and kidney complications, and high frequency of PNPLA3 risk alleles.
- 5The classification intends to tailor interventions, such as prioritizing fibrosis screening or cardiorenal protection, by subtype.
Why It Matters
The use of advanced AI/machine learning in clinical stratification sets a precedent for data-driven, precision approaches in metabolic and cardiometabolic disease management. Implications exist for integration with imaging biomarkers and improving targeted clinical decision-making in radiology and hepatology.
Source
EurekAlert
Related News
•EurekAlert
Researchers Develop All-Optical Synapse for Neuromorphic Imaging Systems
A new artificial synapse, controlled entirely by light, enables in-sensor neuromorphic processing for more efficient and noise-resistant imaging systems.
•EurekAlert
AI-Simulation Approach Achieves 90% Faster Brain MRI with Minimal Data
A simulation-based AI method can reconstruct brain MRI scans with only 10% of the usual data, greatly reducing scan times.
•EurekAlert
Mayo Clinic Showcases Imaging AI and Early Cancer Detection Advances at ASCO 2026
Mayo Clinic researchers will present over 30 studies at ASCO 2026, highlighting new advances in imaging AI, data science, and early cancer detection.